Bioasis Technologies Inc. — Investor Relations & Filings
Filings indexed
120
across all filing types
Latest filing
2023-06-20
Regulatory Filings
Country
CA
Canada
Listing
TSXV
BIOAF
Bioasis Technologies Inc. is a development-stage biopharmaceutical company focused on the research and development of proprietary technologies and products for Central Nervous System (CNS) diseases and brain-related disorders. Its core technology is the xB3 platform, a proprietary system designed to facilitate the transport and delivery of therapeutic agents across the challenging blood-brain barrier (BBB). The company's in-house programs aim to develop both symptomatic and disease-modifying treatments, as well as diagnostic technologies, addressing the limitations inherent in treating complex neurological conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2023-06-20 | English | |
| News release - English.pdf | 2023-03-23 | English | |
| Material change report - English.pdf | 2023-02-01 | English | |
| News release - English.pdf | 2023-01-23 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-01-19 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-01-19 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 13676673 | News release - English.pdf | 2023-06-20 | English | ||
| 13655121 | News release - English.pdf | 2023-03-23 | English | ||
| 13641805 | Material change report - English.pdf | 2023-02-01 | English | ||
| 26889150 | News release - English.pdf | 2023-01-23 | English | ||
| 13640993 | 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-01-19 | English | ||
| 13640992 | 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-01-19 | English | ||
| 13641004 | Interim MD&A - English.pdf | 2023-01-19 | English | ||
| 13640995 | Interim financial statements/report – English.pdf | 2023-01-19 | English | ||
| 13640996 | News release - English.pdf | 2023-01-19 | English | ||
| 13640997 | News release - English.pdf | 2023-01-19 | English | ||
| 13638871 | News release - English.pdf | 2023-01-11 | English | ||
| 13638942 | Other.pdf | 2023-01-11 | English | ||
| 13638941 | Other.pdf | 2023-01-11 | English | ||
| 13638940 | Other.pdf | 2023-01-11 | English | ||
| 13638939 | Other.pdf | 2023-01-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AURORA CANNABIS INC
Global producer and distributor of cannabis for medical and…
|
ACB | US | Manufacturing |
|
AUTOBIO DIAGNOSTICS CO., LTD
Provides IVD solutions for immunoassay, microbiology, and m…
|
603658 | CN | Manufacturing |
|
Autolus Therapeutics plc
Biopharmaceutical company developing programmed T cell ther…
|
AUTL | US | Manufacturing |
|
AVACTA GROUP PLC
Clinical-stage biotech developing targeted oncology drugs w…
|
AVCT | GB | Manufacturing |
|
AVADEL PHARMACEUTICALS PLC
Biopharmaceutical company developing therapies for sleep di…
|
AVDL | US | Manufacturing |
|
Avagenesis Corp.
Develops automated technology for isolating and enriching r…
|
VVA | CA | Manufacturing |
|
Avalon GloboCare Corp.
Develops cell-based immunotherapies and provides precision …
|
ALBT | US | Manufacturing |
|
AVECHO BIOTECHNOLOGY LIMITED
Develops human and animal health products using TPM® drug d…
|
AVE | AU | Manufacturing |
|
Avicanna Inc.
Commercial-stage international biopharma focused on evidenc…
|
AVCN | CA | Manufacturing |
|
Avidity Biosciences, Inc.
Develops a class of RNA therapeutics called Antibody Oligon…
|
RNA | US | Manufacturing |
Bioasis Technologies Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46038/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46038 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46038 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46038 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46038}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bioasis Technologies Inc. (id: 46038)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.